Sars-Cov-2 and risk of antiviral drug resistance
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11845-021-02820-y.pdf
Reference10 articles.
1. World Health Organization (WHO) Coronavirus2019/situation-reports. Situation Reports. https://www.who.int/emergencies/diseases/novel september 2021
2. Wang C, Horby PW, Hayden FG, Gao GF (2020) A novel coronavirus outbreak of global health concern. Lancet 395:470–473
3. Vitiello A, Porta R, Pianesi L, Ferrara F (2021) COVID-19 pandemic: vaccine and new monoclonal antibodies, point of view. Ir J Med Sci. https://doi.org/10.1007/s11845-021-02584-5. Epub ahead of print. PMID: 33710481
4. Tarighi P, Eftekhari S, Chizari M et al (2021) A review of potential suggested drugs for coronavirus disease (COVID-19) treatment. Eur J Pharmacol. 895:173890. https://doi.org/10.1016/j.ejphar.2021.173890. Epub 2021 Jan 20. PMID: 33482181; PMCID: PMC7816644
5. Duwe S (2017) Influenza viruses — antiviral therapy and resistance. GMS Infect Dis 5(Doc04):20
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Antiviral responses versus virus-induced cellular shutoff: a game of thrones between influenza A virus NS1 and SARS-CoV-2 Nsp1;Frontiers in Cellular and Infection Microbiology;2024-02-05
2. Tracing COVID-19 drugs in the environment: Are we focusing on the right environmental compartment?;Environmental Pollution;2023-12
3. Anti-viral effect of usenamine a using SARS-CoV-2 pseudo-typed viruses;Heliyon;2023-11
4. Bacterial Proteases as Potentially Exploitable Modulators of SARS-CoV-2 Infection: Logic from the Literature, Informatics, and Inspiration from the Dog;BioTech;2023-10-30
5. The application of metagenomic next-generation sequencing in pathogen diagnosis: a bibliometric analysis based on Web of Science;Frontiers in Cellular and Infection Microbiology;2023-08-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3